Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque

Journal of Nuclear Medicine

Volumn 51, Issue 6, 2010, Pages 862-865

  Derlin, Thorsten ^a   Richter, Ulrich ^a   Bannas, Peter ^a   Begemann, Philipp ^a   Buchert, Ralph ^b   Mester, Janos ^a   Klutmann, Susanne ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

18F sodium fluoride; Atherosclerosis; Calcification; PET; PET CT; Plaque

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RADIOPHARMACEUTICAL AGENT; SODIUM FLUORIDE F 18; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORIDE SODIUM; FLUORINE;

ABDOMINAL AORTA; AGED; ARTERY CALCIFICATION; ARTERY LESION; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMMON CAROTID ARTERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; THORACIC AORTA; WHOLE BODY IMAGING; ANGIOGRAPHY; ARTERY; ATHEROSCLEROSIS; CALCINOSIS; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

AGED; ANGIOGRAPHY; ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CALCINOSIS; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SODIUM FLUORIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953921203     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.076471     Document Type: Article

References (20)

1. Doherty TM, Asotra K, Fitzpatrick LA, et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA. 2003;100:11201-11206.
2. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144-151.
3. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
4. Fuster V, Lewis A. Conner Memorial Lecture: mechanisms leading to myocardial infarction-insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
5. Detrano RC, Doherty TM, Davies MJ, Stary HC. Predicting coronary events with coronary calcium: pathophysiologic and clinical problems. Curr Probl Cardiol. 2000;25:374-402.
6. Jeziorska M, McCollum C, Wooley DE. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch. 1998;433:559-565.
7. Engelse MA, Neele JM, Bronckers AL, Pannekoek H, de Vries CJ. Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix Gla protein in human atherogenesis. Cardiovasc Res. 2001;52:281-289.
8. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81.
9. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998-2003.
10. Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification: where is the action? Nat Genet. 1999;21:150-151.
11. Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002;106:2026-2034. (Pubitemid 35176312)
12. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831.
13. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245-1250.
14. 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-1284.
15. 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
16. 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans: first results. Eur J Nucl Med Mol Imaging. 2008;35:815-820.
17. 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:1622-1628.
18. Alsaid H, Sabbah M, Bendahmane Z, et al. High-resolution contrast-enhanced MRI of atherosclerosis with digital cardiac and respiratory gating in mice. Magn Reson Med. 2007;58:1157-1163.
19. 18F-FDG PET/CT: when to image? J Nucl Med. 2009;50:854-857.
20. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36:2642-2647.